Popkin J D, Bromer R H, Vaughan C W, Byrne R E, Licciardello J T, Hoffer S M, Welch J M, Fofonoff S A, Strong M S, Hong W K
Am J Clin Oncol. 1983 Jun;6(3):301-4. doi: 10.1097/00000421-198306000-00008.
Sixteen patients with advanced squamous cell carcinoma of the head and neck were treated with a 48-hour I.V. vindesine infusion. The dosage was 3 mg/m2/48 hours every 2 weeks. Toxicity consisted of leukopenia, paresthesias, and phlebitis. Major objective responses were seen in four patients (one CR, three PR), with a median duration of 4 months.
16例晚期头颈部鳞状细胞癌患者接受了48小时的长春地辛静脉输注治疗。剂量为每2周3mg/m²/48小时。毒性反应包括白细胞减少、感觉异常和静脉炎。4例患者出现主要客观缓解(1例完全缓解,3例部分缓解),中位缓解持续时间为4个月。